Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
fluvoxamine maleate, Quantity: 100 mg
Arrotex Pharmaceuticals Pty Ltd
Tablet, film coated
Excipient Ingredients: mannitol; maize starch; pregelatinised potato starch; sodium stearylfumarate; colloidal anhydrous silica; hypromellose; macrogol 6000; purified talc; titanium dioxide
Oral
10 tablets (sample), 30 tablets
(S4) Prescription Only Medicine
* for the treatment of major depression. * for the treatment of Obsessive Compulsive Disorder (OCD) in children aged 8 years and older and adults.
Visual Identification: oval, biconvex, scored, white film-coated tablet one side inscribed with '313' on either side of the score line on one face and plain on the other face.; Container Type: Blister Pack; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
1998-05-27
FAVERIN- Consumer Medicine Information Page 1 of 5 FAVERIN TABLETS _fluvoxamine maleate _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET THIS LEAFLET ANSWERS SOME OF THE COMMON QUESTIONS ABOUT FAVERIN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. PLEASE READ THIS LEAFLET BEFORE YOU START TAKING FAVERIN. If you are helping someone else take FAVERIN, please read this leaflet before you give the first dose. All medicines have risks and benefits. Your doctor has weighed the risks of you taking FAVERIN against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING FAVERIN, ASK YOUR DOCTOR OR PHARMACIST. Your doctor and pharmacist have more information. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT FAVERIN IS USED FOR FAVERIN belongs to a family of medicines known as selective serotonin reuptake inhibitors (SSRIs). It is used to treat depression in adults and a condition known as "Obsessive Compulsive Disorder" (OCD) in adults and children eight years of age or older. Both of these conditions are thought to be caused by a chemical imbalance in parts of the brain. FAVERIN corrects this chemical imbalance and may help relieve the symptoms of depression and OCD. Depression is longer lasting and/or more severe than the "low moods" everyone has from time to time due to the stress of everyday life. Depression caused by a chemical imbalance in the brain can affect your whole body and can cause emotional and physical symptoms such as feeling low in spirit, loss of interest in activities, being unable to enjoy life, poor appetite or overeating, disturbed sleep, often waking up early, loss of sex drive, lack of energy and feeling guilty for no reason. People with OCD can have two types of symptoms – obsessions and compulsions. Obsessions are unwanted repeated thoughts or feelings, which are ongoing. Compulsions are the need to repeat actions over and over. The symptoms of OCD can vary Read the complete document
1 AUSTRALIAN PRODUCT INFORMATION FAVERIN (FLUVOXAMINE MALEATE) TABLETS 1 NAME OF THE MEDICINE Fluvoxamine maleate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet of FAVERIN contains 50 mg or 100mg of fluvoxamine maleate. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM FAVERIN (fluvoxamine maleate) 100 mg: Oval, biconvex, scored, white film-coated tablet one side inscribed with '313' on either side of the score line on one face and plain on the other face. FAVERIN (fluvoxamine maleate) 50 mg: Round, biconvex white film coated scored tablets inscribed with “291” on either side of the score line and other face plain. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS FAVERIN (fluvoxamine maleate) is indicated for the treatment of major depression in adults. FAVERIN (fluvoxamine maleate) is also indicated for the treatment of Obsessive-Compulsive Disorder (OCD) in both children aged 8 years and older, adolescents and adults. 4.2 D OSE AND METHOD OF ADMINISTRATION D EPRESSION The recommended starting dose of fluvoxamine is 50mg per day for one week, given as a single dose in the evening. Doses should be gradually increased (by 50mg per week) until an effective dose is reached, with a maximum of 300mg per day. (The usually effective dose is 100mg/day.) 2 Doses up to 150mg can be given as a single dose. It is recommended that total daily doses of greater than 150mg be given in 2 or 3 divided doses. If no improvement is observed within 6 weeks of initiation of therapy, treatment with fluvoxamine should be reconsidered. It is important to ascertain that an adequate therapeutic dose has been maintained throughout this period. In agreement with the consensus statement of the WHO, antidepressant medication should be continued for at least 6 months after recovery from a depressive episode. O BSESSIVE C OMPULSIVE D ISORDER Adults: The recommended starting dose of fluvoxamine is 50mg per day for 3 to 4 days. The dosage should be increased gradually (i.e. by 50mg every 4 to Read the complete document